ROIV — ROIVANT SCIENCES LTD
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ROIV?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 1 tracked investors who changed their ROIV position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 56/100 in a Overheat regime).
- +6 tracked investors reported holding ROIV at their latest filing
- +Macro Health is 56/100 in a Overheat regime — historically acceptable for this sectorsource
- −1 tracked investor reduced or exited last quarter (1 reduced, 0 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/18/2026.
About ROIVANT SCIENCES LTD (ROIV)
ROIVANT SCIENCES LTD (ROIV) appears in the most recent 13F filings of 6 tracked institutional investors. The largest disclosed position is held by Andreas Halvorsen (Viking Global Investors), valued at $624M. Across recent filings, tracked investors recorded 5 new positions, 5 increased, 11 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ROIV
How many top investors track ROIV
Several tracked investors have exposure.
ROIV Ownership Composition
How ROIVANT SCIENCES LTD is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant56.4%
- Other32.1%
- Value & Distressed11.0%
- Macro0.5%
Tracked investors currently reporting ROIV
- Andreas HalvorsenJun 30, 2026Viking Global InvestorsShares6.3MValue$221.9M% Portfolio0.63%
- Ken GriffinJun 30, 2026Citadel AdvisorsShares5.8MValue$205.7M% Portfolio0.02%
- Steve CohenJun 30, 2026Point72 Asset ManagementShares4.5MValue$159.1M% Portfolio0.18%
- David EinhornJun 30, 2026DME Capital Management, LPShares2.2MValue$76.2M% Portfolio1.95%
- Izzy EnglanderJun 30, 2026Millennium ManagementShares700.5KValue$24.8M% Portfolio0.01%
- Paul Tudor JonesJun 30, 2026Tudor Investment CorpShares95.1KValue$3.4M% Portfolio0.00%
Recent activity
- $44.2MMay 15, 2024
- Increased$50.9M(14.81%)Aug 14, 2024
- Increased$61.3M(10.33%)Nov 14, 2024
- Reduced$62.4M(-0.70%)Feb 14, 2025
- Increased$54.9M(3.23%)May 15, 2025
- Reduced$51.3M(-16.36%)Aug 14, 2025
- Reduced$34.4M(-50.00%)Nov 14, 2025
- Reduced$44.9M(-9.06%)Feb 17, 2026
- Increased$59.6M(4.03%)May 15, 2026
- Unchanged$76.2M(0.00%)Aug 14, 2026
- Reduced$565.6M(-11.63%)Feb 14, 2025
- Reduced$464.3M(-3.76%)May 15, 2025
- Reduced$385.9M(-25.59%)Aug 14, 2025
- Reduced$357M(-31.09%)Nov 14, 2025
- Reduced$139.8M(-72.69%)Feb 17, 2026
- Increased$184.3M(3.25%)May 15, 2026
- Reduced$221.9M(-5.73%)Aug 14, 2026
- New$206KFeb 13, 2026
- Sold$0(-100.00%)May 15, 2026
- Sold$0(-100.00%)Nov 14, 2024
- Reduced$534.8K(-70.84%)Aug 14, 2024
- Sold$0(-100.00%)Nov 14, 2024
- New$6.8MSep 16, 2024
- $1.8MMay 15, 2024
- $624.3MNov 14, 2024
Frequently asked questions
- How many institutional investors hold ROIV?
- 6 tracked institutional investors disclosed a position in ROIV (ROIVANT SCIENCES LTD) in their most recent 13F filing.
- Who is the largest institutional holder of ROIV?
- Andreas Halvorsen, Viking Global Investors, holds the largest disclosed position in ROIV, valued at $624M.
- Did institutional ownership of ROIV increase or decrease?
- Across recent 13F filings, tracked investors recorded 5 new positions, 5 increased, 11 reduced, and 3 fully exited ROIV.
- Where does this ROIV ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.